Financials

  • Market Capitalization 3.7 B
  • Employee 1 184
  • Founded 2015
  • CEO Christian Behrenbruch
  • Website www.telixpharma.com
  • Headquarter Australia
  • FIGI BBG01N69K900
  • Industry Biotechnologie
Gesamtumsatz
Jahresüberschuss
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente

Related tickers

#NamePreis24h %7d %1M %1J %MarktkapitalisierungLetzte 7 Tage
1500
RLAY
Relay Therapeutics, Inc. - Common Stock
17.36 USD-3.45%-5.65%-8.39%+183.66%3.80 B USD
1511
TNGX
Tango Therapeutics, Inc. - Common Stock
22.22 USD-8.07%+2.68%-7.34%+165.47%3.75 B USD
1559
VCYT
Veracyte, Inc. - Common Stock
43.11 USD-2.07%-2.11%+4.94%+16.83%3.47 B USD
1581
XENE
Xenon Pharmaceuticals Inc. - Common Shares
34.42 USD-3.88%-4.89%-42.01%-15.62%3.33 B USD